SEC EDGAR · Federal Reserve · FDA · BLS · Updated every 60s
GRI Bio announced FDA Orphan Drug Designation for GRI-0621 (Tazarotene) to treat Idiopathic Pulmonary Fibrosis, a rare progressive lung disease. The d...
Centrus Energy Corp. executed a Seventh Amendment to its Section 382 Rights Agreement, extending the Final Expiration Date to June 30, 2029 and adjust...
BCB Bancorp's board voted to suspend quarterly cash dividends on common and preferred stock, conserving approximately $1.86 million per quarter during...
Volato Group and investors amended the registration rights agreement to set the filing date for the Initial Registration Statement at 5:30 p.m. ET on ...
Momentus Inc. registered an offering of up to $75 million in Class A common stock through a Sales Agreement with A.G.P./Alliance Global Partners, as d...
Broadway Financial Corporation appointed Tina Carew as Executive Vice President, Chief Legal Officer and Corporate Secretary, bringing 29 years of fin...
Mondelez International appointed Amit Banati as Executive Vice President and Chief Financial Officer, replacing Luca Zaramella who transitions to Chie...
Bitmine Immersion Technologies announced a cash dividend of $0.1056 per share on its 9.50% Series A Perpetual Preferred Stock, payable July 10, 2026. ...
KKR Infrastructure Conglomerate disclosed its net asset value composition with investments at fair value of $6.94B across multiple share classes. The ...
Willdan Group, Inc. filed an amended and restated version of its 2008 Performance Incentive Plan to govern equity awards for eligible employees, direc...
Sonoma Pharmaceuticals received legal counsel opinion for a proposed $3.6 million common stock offering under an at-market issuance agreement with Lad...
SharkNinja, Inc. adopted amended and restated memorandum and articles of association under Cayman Islands law, effective June 18, 2026. The filing est...
GCT Semiconductor Holding, Inc. filed an 8-K exhibiting a legal opinion on its $120 million at-the-market (ATM) offering of common stock under a Sales...
Protagonist Therapeutics' board adopted and stockholders approved a new 2026 Equity Incentive Plan on June 17, 2026, succeeding the prior 2016 plan. T...
Centrus Energy signed a letter of intent to provide high-assay low-enriched uranium (HALEU) to Oklo Inc. for multiple Aurora powerhouse deployments in...
The company entered into a transition agreement with Patrick Kirscht, Chief Credit Officer, establishing an orderly separation by June 15, 2026. Kirsc...
John Rogers Jr., who has served on Nike's board since 2018, will retire following the September 2026 Annual Meeting of Shareholders and transition to ...
Tidewater Inc.'s board adopted an amendment to increase authorized shares under its 2021 Stock Incentive Plan to 4.75 million shares, subject to stock...
C&F Financial has entered into a transition agreement with President and CEO S. Dustin Crone, who will step down as President effective June 30, 2026 ...
Epsilon Energy Ltd. filed an at-the-market (ATM) offering agreement with Roth Capital Partners to sell up to $15 million in common shares. The offerin...